`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`LIQUIDIA TECHNOLOGIES, INC.,
`Petitioner
`
`v.
`
`UNITED THERAPEUTICS CORPORATION,
`Patent Owner
`
`
`
`
`Case No. IPR2021-00406
`U.S. Patent No. 10,716,793
`
`
`
`
`PETITIONER’S UNOPPOSED MOTION TO FILE UNDER SEAL
`
`
`
`
`
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`Pursuant to 37 C.F.R. § 42.54, Petitioner Liquidia Technologies, Inc. hereby
`
`submits this Motion to Seal Exhibit 1132 filed in support of Petitioner’s Reply to
`
`Petition filed concurrently herein.
`
`I.
`
`Good Cause Exists for Sealing Certain Confidential Information
`
`The Patent Trial and Appeal Board, Consolidated Trial Practice Guide
`
`November 2019 (“Guide”) provides that “the rules aim to strike a balance between
`
`the public’s interest in maintaining a complete and understandable file history and
`
`the parties’ interest in protecting truly sensitive information.” Guide at 19; 77 Fed.
`
`Regs. 48756, 48760 (Aug. 14, 2012). These rules “identify confidential information
`
`in a manner consistent with Federal Rule of Civil Procedure 26(c)(1)(G), which
`
`provides for protective orders for trade secret or other confidential research,
`development, or commercial information.” Id. (citing 37 C.F.R. § 42.54).
`
`Exhibit 1132 includes excerpts from a deposition transcript generated on
`
`January 15, 2022 in the United Therapeutics Corp. v. Liquidia Tech. Inc., Case No.
`
`1:20-cv-00755 (D. Del.) litigation. The transcript was designated as “Highly
`
`Confidential” in its entirety by United Therapeutics Corporation, Patent Owner in
`
`this proceeding and plaintiff in the Delaware litigation. (Ex. 1132, 2.) Accordingly,
`
`Petitioner Liquidia files these excerpts under seal in this proceeding per its
`
`obligations under the district court protective order, and per Patent Owner’s lack of
`
`objection to Petitioner doing so. Patent Owner is the party with knowledge as to
`
`
`
`1
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`why good cause exists for the confidentiality designation and why the “‘highly
`
`confidential nature of’ the information contained in those documents makes it
`
`‘impossible to reasonably redact [them] for public disclosure.” Purdue Pharma L.P.
`
`v. Depomed, Inc., IPR2014-00377, Paper No. 62, at 4 (PTAB March 17, 2015).
`
`II. Certification of Non-Publication
`
` On behalf of Petitioner, the undersigned counsel certifies that, to the best of
`
`their knowledge, the information sought to be sealed by this Motion to Seal has not
`
`been published or otherwise made public. Efforts to maintain the confidentiality of
`
`this information have been undertaken by Petitioner in the related proceeding noted
`
`above.
`
`III. Certification of Conference with Opposing Party Pursuant to 37
`C.F.R. § 42.54
`Petitioner has conferred with Patent Owner about both the PTAB’s Default
`
`Protective Order and this Motion to Seal relating to Patent Owner’s confidential
`
`information. The parties have agreed to be bound by the PTAB’s Default Protective
`
`Order, and agreed to the filing of Ex. 1132 under the Default Protective Order. Per
`
`Appendix B of the Guide, the Default Protective Order is not being separately filed.
`
`IV. Protective Order
`
`The confidential information will be subject to the Default Protective Order
`
`from the Guide, to which the parties have agreed to be bound in this proceeding.
`
`
`
`2
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`V. Conclusion
`
`For the reasons stated above, Petitioner respectfully requests that Exhibit
`
`1132 remain under seal.
`
`Dated: February 10, 2022
`
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue NW
`Suite 700
`Washington, DC 20004
`Tel: (212) 479-6840
`Fax: (212) 479-6275
`
`
`
`
`
`Respectfully submitted,
`
`
`
`By:
`
`
`
`
`/Ivor R. Elrifi/
`Ivor R. Elrifi
`Reg. No. 39,529
`Counsel for Petitioner
`
`
`
`3
`
`
`
`IPR2021-00406
`U.S. Patent No. 10,716,793
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. §§42.6(e)(4)(i) et seq., a complete copy of the attached
`PETITIONER’S UNOPPOSED MOTION TO SEAL is being served via
`electronic mail on the 10th day of February 2022, upon Patent Owner’s attorneys
`of record:
`
`Stephen B. Maebius (smaebius@foley.com)
`UT-793@foley.com
`UTCvLiquidia-IPR@mwe.com
`
`
`Dated: February 10, 2022
`
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue NW
`Suite 700
`Washington, DC 20004
`Tel: (212) 479-6840
`Fax: (212) 479-6275
`
`
`
`/Ivor R. Elrifi/
`Ivor R. Elrifi
`Reg. No. 39,529
`Counsel for Petitioner
`
`
`
`By:
`
`
`
`
`
`
`
`
`
`
`4
`
`